Research
ARU experts shape new report to help young carers
Recommendations by APPG are presented to policymakers at Houses of Parliament.
Gene therapies for wet AMD: reshaping the blockbuster anti‑VEGF market
This month, VacZine Analytics, a specialist publisher in healthcare commercial analysis, releases a brand-new global forecast focused on new gene therapies for Wet age-related macular degeneration (wet AMD). ...
Agri-Tech Meets ...
Agri-Tech Meets is a series of networking meetings exploring the exciting innovation opportunities at the interface between agri-tech and other sectors. ...
CWIC 2026 Call for Speakers Now Open
Share your insights on connectivity's evolving role at the premier telecommunications and ACT event. ...
Future Communications at the Edge
This Academic & Industry SIG event will share the latest research from our UK Universities to explore how we shape and deliver secure connectivity, advanced network systems, and cloud integration ...
CamAWiSE social evening
CamAWiSe social evening for local STEMM professionals and the participants of the CamAWiSE Mentoring programme. ...
Introducing PhiZ & Co: Practical patient engagement for growing life science teams
One of the strengths of the Cambridge life sciences community is how openly teams share both challenges and progress. And one key question many founders, researchers, and innovators are facing is: how do you meaningfully involve patients in early research plans or content creation when ...
ELRIG Cell and Gene Therapy 2026
Event OverviewDiscover the breakthroughs shaping the future of medicine at this two-day event designed for scientists, innovators, and industry leaders. Our programme combines cutting-edge talks, interactive panel discussions, and dedicated networking opportunities to foster collaborati...
ELRIG Announces Drs Stephen Ward and Annarita Miccio as Keynote Speakers for Cell and Gene Therapy 2026
Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK. Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy ...
What AI in healthcare really needs
Co-authored by By Claudio Silvestrin